Idiopathic thrombocytopenic purpura: pathogenesis and potential therapeutic approach

被引:12
作者
Zhao, Xiaohong [1 ]
Qi, Xiaomei [1 ]
Wang, Chen [1 ]
Zhou, Zhonghao [1 ]
Cao, Haiwu [1 ]
Wu, Pin [1 ]
Li, Linghao [1 ]
Lu, Shiyun [1 ]
Wang, Zhi [1 ]
机构
[1] Nanjing Med Univ, Wuxi Peoples Hosp 2, Dept Hematol, 68 Zhongshan Rd, Wuxi 214002, Peoples R China
关键词
Idiopathic thrombocytopenic purpura; Etiology; Therapeutics;
D O I
10.23736/S0026-4806.17.05252-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: This study sought to clarify the pathogenesis of idiopathic thrombocytopenic purpura (ITP) and make preliminary investigations regarding a therapeutic approach. METHODS: Enzyme-linked immunosorbent assay was used to establish and analyze the standard curve for interferon (IFN)gamma, interleukin (IL) 4, and IL-17 in order to determine a measurement method for these cytokines. Subsequently, cellular levels of IFN-gamma, IL-4, and IL-17 in the peripheral blood of patients in the treatment group (traditional Chinese medicine) was compared with those in the control group (Western-style care). An ITP mice model was also established and treated with different medications. RESULTS: Th1/Th2 cell quantities in ITP patients were significantly higher than in healthy individuals (P<0.05). Furthermore, IL-17 secreted by Th17 cells was significantly higher in ITP patients than healthy individuals (P<0.01). A combination of traditional Chinese medicine and Western-style care yielded the best treatment effect for ITP mice, followed by Western medicine alone and then Chinese medicine alone. CONCLUSIONS: The experimental results suggested that Th17 cells may be more related to the pathogenesis of ITP, and that application of Western-style care supplemented by traditional Chinese medicine may yield a more optimal treatment for ITP.
引用
收藏
页码:502 / 506
页数:5
相关论文
共 19 条
[1]  
Alam MM, 2014, J PAK MED ASSOC, V64, P1358
[2]  
Arbore G, 2016, SCIENCE, V16, P234
[3]   Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells [J].
Bettelli, E ;
Carrier, YJ ;
Gao, WD ;
Korn, T ;
Strom, TB ;
Oukka, M ;
Weiner, HL ;
Kuchroo, VK .
NATURE, 2006, 441 (7090) :235-238
[4]   Medical progress: Immune thrombocytopenic purpura. [J].
Cines, DB ;
Blanchette, VS .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (13) :995-1008
[5]  
Eken A, 2016, J IMMUNOL, V196
[6]   CD4+ T cell differentiation in infection: amendments to the Th1/Th2 axiom [J].
Jankovic, Dragana ;
Feng, Carl G. .
FRONTIERS IN IMMUNOLOGY, 2015, 6
[7]   Effects of additional treatment of sarpogrelate to aspirin therapy on platelet aggregation and plasma plasminogen activator inhibitor activity in patients with stable effort angina [J].
Kajiwara, Ichiro ;
Soejima, Hirofumi ;
Miyamoto, Shinzo ;
Ogawa, Hisao .
THROMBOSIS RESEARCH, 2011, 128 (06) :547-551
[8]   Drug-Eluting Balloon in Peripheral Intervention for Below the Knee Angioplasty Evaluation (DEBATE-BTK): A Randomized Trial in Diabetic Patients With Critical Limb Ischemia [J].
Liistro, Francesco ;
Porto, Italo ;
Angioli, Paolo ;
Grotti, Simone ;
Ricci, Lucia ;
Ducci, Kenneth ;
Falsini, Giovanni ;
Ventoruzzo, Giorgio ;
Turini, Filippo ;
Bellandi, Guido ;
Bolognese, Leonardo .
CIRCULATION, 2013, 128 (06) :615-621
[9]  
Nakada Y, 2015, CASE REP NEPHROL, V2015
[10]   The Role of Indigenous Microorganisms in the Biodegradation of Naturally Occurring Petroleum, the Reduction of Iron, and the Mobilization of Arsenite from West Bengal Aquifer Sediments [J].
Rowland, H. A. L. ;
Boothman, C. ;
Pancost, R. ;
Gault, A. G. ;
Polya, D. A. ;
Lloyd, J. R. .
JOURNAL OF ENVIRONMENTAL QUALITY, 2009, 38 (04) :1598-1607